Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-013531
Filing Date
2019-02-26
Accepted
2019-02-26 16:25:28
Documents
1
Period of Report
2019-02-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6624
  Complete submission text file 0001209191-19-013531.txt   7934
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS INC (Issuer) CIK: 0001439222 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 38 SIDNEY STREET, 2ND FLOOR CAMBRIDGE MA 02139
Business Address
Bowden Christopher (Reporting) CIK: 0001608601 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36014 | Film No.: 19633772